Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

NCT00589381

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
View Trial Details
Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

NCT00029224

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +31 more
Locations
  • Stockton Hematology Oncology Medical Group Stockton, California, United States
  • Osceola Cancer Center Kissimmee, Florida, United States
  • Nevada Cancer Center Las Vegas, Nevada, United States
  • Hematology-Oncology Associates PC Albuquerque, New Mexico, United States
View Trial Details
Completed

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

NCT00608907

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hematology Institute - Davidoff Center - Rabin Medical Center Petah Tikva, Israel
  • Divisione di Ematologia - Ospedale S Eugenio - P. le dell'Umanesimo Rome, Italy
  • Medical Academy - Dept of Hematology and Transplantology Gdansk, Poland
  • Klinika Nowotworow Ukladu - Chlonnego - Centrum Onkologii - Instytut Warsaw, Poland
View Trial Details

Related conditions